These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10348805)

  • 21. Time dependent pharmacokinetics of albendazole in human.
    Mirfazaelian A; Rouini MR; Dadashzadeh S
    Biopharm Drug Dispos; 2003 Jul; 24(5):199-204. PubMed ID: 12784319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in plasma and abomasal kinetics of albendazole and its metabolites in calves grazed on pasture or fed a grain-based diet.
    Sánchez S; Alvarez L; Pis A; Quiroga M; Lanusse C
    Res Vet Sci; 1999 Jun; 66(3):223-30. PubMed ID: 10333463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose dependent pharmacokinetics of albendazole in human.
    Mirfazaelian A; Rouini MR; Dadashzadeh S
    Biopharm Drug Dispos; 2002 Dec; 23(9):379-83. PubMed ID: 12469331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mouflon (Ovis musimon) dicrocoeliosis: effects of parasitosis on the activities of biotransformation enzymes and albendazole metabolism in liver.
    Skálová L; Krízová V; Cvilink V; Szotáková B; Storkánová L; Velík J; Lamka J
    Vet Parasitol; 2007 May; 146(3-4):254-62. PubMed ID: 17386978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative plasma disposition of fenbendazole, oxfendazole and albendazole in dogs.
    Gokbulut C; Bilgili A; Hanedan B; McKellar QA
    Vet Parasitol; 2007 Sep; 148(3-4):279-87. PubMed ID: 17673370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ex vivo diffusion of albendazole and its sulfoxide metabolite into ascaris suum and Fasciola hepatica.
    Alvarez LI; Mottier ML; Sánchez SF; Lanusse CE
    Parasitol Res; 2001 Nov; 87(11):929-34. PubMed ID: 11728018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effect of Protein Restriction in the In Vitro Metabolism of Albendazole in Rats.
    Belaz KR; de O Cardoso J; da Silva CA; Oliveira RV
    Drug Metab Lett; 2015; 9(1):8-16. PubMed ID: 25827239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disposition of netobimin, albendazole, and its metabolites in the pregnant rat: developmental toxicity.
    Cristòfol C; Navarro M; Franquelo C; Valladares JE; Carretero A; Ruberte J; Arboix M
    Toxicol Appl Pharmacol; 1997 May; 144(1):56-61. PubMed ID: 9169069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enantioselective analysis of albendazole sulfoxide in cerebrospinal fluid by capillary electrophoresis.
    Paias FO; Lanchote VL; Takayanagui OM; Bonato PS
    Electrophoresis; 2001 Sep; 22(15):3263-9. PubMed ID: 11589289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Albendazole sulphoxide kinetic disposition after treatment with different formulations in dogs.
    Dib A; Palma S; Suárez G; Farías C; Cabrera P; Castro S; Allemandi D; Moreno L; Lanusse C; Sánchez Bruni S
    J Vet Pharmacol Ther; 2011 Apr; 34(2):136-41. PubMed ID: 21395604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro ruminal biotransformation of benzimidazole sulphoxide anthelmintics: enantioselective sulphoreduction in sheep and cattle.
    Virkel G; Lifschitz A; Pis A; Lanusse C
    J Vet Pharmacol Ther; 2002 Feb; 25(1):15-23. PubMed ID: 11874522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of surfactants on oral bioavailability of albendazole based on the formation of the sulphoxide metabolites in rats.
    Redondo PA; Alvarez AI; García JL; Villaverde C; Prieto JG
    Biopharm Drug Dispos; 1998 Jan; 19(1):65-70. PubMed ID: 9510986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism and depletion of albendazole in the muscle tissue of channel catfish following oral treatment.
    Shaikh B; Rummel N; Gieseker C; Reimschuessel R
    J Vet Pharmacol Ther; 2006 Dec; 29(6):525-30. PubMed ID: 17083456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ginseng increases intestinal elimination of albendazole sulfoxide in the rat.
    Merino G; Molina AJ; García JL; Pulido MM; Prieto JG; Alvarez AI
    Comp Biochem Physiol C Toxicol Pharmacol; 2003 Sep; 136(1):9-15. PubMed ID: 14522595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I biotransformation of albendazole in lancet fluke (Dicrocoelium dendriticum).
    Cvilink V; Szotáková B; Krízová V; Lamka J; Skálová L
    Res Vet Sci; 2009 Feb; 86(1):49-55. PubMed ID: 18565554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis.
    Pourgholami MH; Akhter J; Wang L; Lu Y; Morris DL
    Cancer Chemother Pharmacol; 2005 May; 55(5):425-32. PubMed ID: 15565325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioavailability comparison between albendazole and albendazole sulphoxide in rats and man.
    Dominguez L; Fagiolino P; Gordon S; Manta E
    Farmaco; 1995 Oct; 50(10):697-702. PubMed ID: 8590577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of repeated doses of albendazole on enantiomerism of its sulfoxide metabolite in goats.
    Benoit E; Besse S; Delatour P
    Am J Vet Res; 1992 Sep; 53(9):1663-5. PubMed ID: 1416373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the interaction between ivermectin and albendazole following their combined use in lambs.
    Alvarez L; Lifschitz A; Entrocasso C; Manazza J; Mottier L; Borda B; Virkel G; Lanusse C
    J Vet Pharmacol Ther; 2008 Jun; 31(3):230-9. PubMed ID: 18471144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Giardia duodenalis: Flavohemoglobin is involved in drug biotransformation and resistance to albendazole.
    Pech-Santiago EO; Argüello-García R; Vázquez C; Saavedra E; González-Hernández I; Jung-Cook H; Rafferty SP; Ortega-Pierres MG
    PLoS Pathog; 2022 Sep; 18(9):e1010840. PubMed ID: 36166467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.